| Drug Name |
Ocriplasmin |
| Drug ID |
BADD_D01594 |
| Description |
Ocriplasmin is a recombinant truncated form of human plasmin with a molecular weight of 27.2 kDa produced by recombinant DNA technology in a Pichia pastoris expression system. Ocriplasmin is a protein made up of 249 amino acids and has two peptide chains. Agent for pharmacologic vitreolysis; thrombolytic agent. FDA approved in October 17, 2012. |
| Indications and Usage |
Ocriplasmin is a proteolytic enzyme indicated for the treatment for symptomatic vitreomacular adhesion. |
| Marketing Status |
approved |
| ATC Code |
S01XA22 |
| DrugBank ID |
DB08888
|
| KEGG ID |
D09646
|
| MeSH ID |
C054561
|
| PubChem ID |
Not Available
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
Not Available |
| UNII |
7V6HE3DM5A
|
| Synonyms |
microplasmin | ocriplasmin |
